New accounts show that Cork-based HIV and hepatitis C drug maker had bumper year in 2021 driven by sales of Covid-19 drug Veklury
Gilead Sciences
US pharma giant, which employs 500 people in Ireland, says development will facilitate additional future investment in the State
Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
Docklands site will run clinical trials for paediatric versions of current and future drugs
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Shareholder proposal demands pharma group open up Covid-19 vaccine tech to poorer countries
The loss last year followed a pre-tax profit of $288.4m in 2019
Mucormycosis cases soar to 30,000 from negligible levels within three weeks
Company seeking alternative roles for staff after loss of contract with Gilead Sciences
Company said the Covid-19 pandemic continues to affect its sales, but growth expected
World round-up: India’s daily rise in cases stays below 40,000 for fourth day
Stoxx Europe 600 Index headed for its third week of gains
Expert WHO panel finds ‘no evidence’ that antiviral drug improves patient outcomes
European markets still post biggest weekly drop in a month
YOU MAY ALSO LIKE...
Inquests into the nightclub fire that led to the deaths of 48 people
A project examining attitudes about the future of Ireland
Weddings, Births, Deaths and other family notices